Vivos Therapeutics, Inc.VVOSNASDAQ
Loading
Revenue ScalingExpanding
Percentile Rank100
3Y CAGR+2.6%
5Y CAGR+5.8%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
+2.6%/yr
vs +43.4%/yr prior
5Y CAGR
+5.8%/yr
Recent deceleration
Acceleration
-40.8pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.3x
Solid growth
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$17.32M+15.2%
2024$15.03M+8.9%
2023$13.80M-13.9%
2022$16.02M-5.1%
2021$16.89M+29.2%
2020$13.07M+14.7%
2019$11.39M+200.4%
2018$3.79M-